Nkarta, Inc. is a clinical-stage biopharmaceutical company located in South San Francisco, California, dedicated to pioneering advanced cell therapies for the treatment of cancer. Utilizing its proprietary technology platform, Nkarta is developing innovative therapies that leverage the immune system to effectively target and eradicate cancer cells. The company boasts a strong pipeline of product candidates in multiple clinical development phases, positioning itself as a key player in addressing significant unmet needs in oncology and shaping the future of cancer treatment.
Click "Analyze" to generate stock analysis
NKTX Price Trend and Signals
NKTX Option Volumes & Open Interests (aggregated)
NKTX Put Call Ratios and IV (aggregated)
NKTX Financials
2025-10-27Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-24Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-23Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-15Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-14Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-09Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.